1. Home
  2. RCKT vs INVX Comparison

RCKT vs INVX Comparison

Compare RCKT & INVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • INVX
  • Stock Information
  • Founded
  • RCKT 1999
  • INVX 2024
  • Country
  • RCKT United States
  • INVX United States
  • Employees
  • RCKT N/A
  • INVX N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • INVX
  • Sector
  • RCKT Health Care
  • INVX
  • Exchange
  • RCKT Nasdaq
  • INVX NYSE
  • Market Cap
  • RCKT 1.1B
  • INVX 954.4M
  • IPO Year
  • RCKT N/A
  • INVX N/A
  • Fundamental
  • Price
  • RCKT $10.47
  • INVX $16.68
  • Analyst Decision
  • RCKT Strong Buy
  • INVX Sell
  • Analyst Count
  • RCKT 10
  • INVX 1
  • Target Price
  • RCKT $48.80
  • INVX $15.00
  • AVG Volume (30 Days)
  • RCKT 1.3M
  • INVX 361.5K
  • Earning Date
  • RCKT 03-04-2025
  • INVX 03-04-2025
  • Dividend Yield
  • RCKT N/A
  • INVX N/A
  • EPS Growth
  • RCKT N/A
  • INVX 175.29
  • EPS
  • RCKT N/A
  • INVX 6.87
  • Revenue
  • RCKT N/A
  • INVX $543,306,000.00
  • Revenue This Year
  • RCKT N/A
  • INVX N/A
  • Revenue Next Year
  • RCKT $225,168.40
  • INVX $8.79
  • P/E Ratio
  • RCKT N/A
  • INVX $2.42
  • Revenue Growth
  • RCKT N/A
  • INVX N/A
  • 52 Week Low
  • RCKT $9.33
  • INVX $12.54
  • 52 Week High
  • RCKT $31.47
  • INVX $25.19
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 45.20
  • INVX N/A
  • Support Level
  • RCKT $9.33
  • INVX N/A
  • Resistance Level
  • RCKT $11.09
  • INVX N/A
  • Average True Range (ATR)
  • RCKT 0.52
  • INVX 0.00
  • MACD
  • RCKT 0.11
  • INVX 0.00
  • Stochastic Oscillator
  • RCKT 53.77
  • INVX 0.00

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

About INVX INNOVEX INTERNATIONAL INC

Innovex International Inc designs, manufactures, and installs mission-critical drilling & deployment, well construction, completion, production, and fishing & intervention solutions to support upstream onshore and offshore activities worldwide. Its comprehensive portfolio extends throughout the lifecycle of the well; and innovative product integration ensures seamless transitions from one well phase to the next, driving efficiency, lowering cost, and reducing the rig site service footprint for the customer. With locations throughout North America, Latin America, Europe, the Middle East, and Asia, The team is readily available with technical expertise, conventional and innovative technologies, and ever-present customer service.

Share on Social Networks: